Eliana Rulli

Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients

R. Labianca, L. Frontini, V. Zagonel, 2017, British Journal of Cancer.